Biofarm will invest 47 million lei in upgrading equipment and developing a new R&D center by 2025.
Raluca Ioana Draghici
Economy
www.shutterstock.com
Always see our news on Google
Biofarm, a leading Romanian drug manufacturer, plans to invest 47 million lei in upgrading its production plant on Logofătul Tăutu Street and developing a new research and development center. The project aims to modernize equipment in order to improve the efficiency of manufacturing processes and better respond to market demands. CEO Cătălin Vicol emphasizes that this initiative is part of Biofarm's strategy to increase its presence on international markets.
Sources
Producătorul de medicamente Biofarm are în plan modernizarea primei fabrici din Bucureşti şi un centru nou de cercetare. Bugetul de investiţii al Biofarm în 2025 este de 47 mil. lei (aproape 10 mil. euro), în creştere faţă de anul anterior, cand a fost de 31 mil. lei
Producătorul de medicamente Biofarm are în plan modernizarea primei fabrici din Bucureşti şi un centru nou de cercetare
Latest News
10:26
The Commission maintains the battery recycling targets and points to the need to expand treatment capacity in the EU
10:11
Saudi Arabia shuts down the East-West pipeline, which transported 5% of the world’s oil, following a massive drone attack on oil infrastructure
09:52
Alert in Bulgaria after an explosion caused a fire at an EMCO weapons depot
09:35
Kirilo Budanov: Europe is beginning to understand the threat of Russia's hybrid warfare
09:16
Alexander Zverev - Ben Shelton, the men's final at the 2026 US Open
See more news
NEWS ON THE SAME TOPICS
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
